{"id":"NCT01358175","sponsor":"Novartis Pharmaceuticals","briefTitle":"16 Week Efficacy and 2 Year Long Term Safety and Efficacy of Secukinumab in Patients With Active Ankylosing Spondylitis","officialTitle":"A Randomized, Double-blind, Placebo-controlled, Multicenter Study of Secukinumab to Demonstrate the 16 Week Efficacy and to Assess the Long Term Safety, Tolerability and Efficacy up to 2 Years in Patients With Active Ankylosing Spondylitis","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2011-10","primaryCompletion":"2014-12","completion":"2014-12","firstPosted":"2011-05-23","resultsPosted":"2017-01-27","lastUpdate":"2017-03-09"},"enrollment":371,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"QUADRUPLE","primaryPurpose":"TREATMENT"},"conditions":["Ankylosing Spondylitis"],"interventions":[{"type":"DRUG","name":"Secukinumab (75 mg)","otherNames":[]},{"type":"DRUG","name":"Secukinumab (150 mg)","otherNames":[]},{"type":"DRUG","name":"Placebo","otherNames":[]}],"arms":[{"label":"Secukinumab 10 mg/kg i.v. / 75 mg s.c.","type":"EXPERIMENTAL"},{"label":"Secukinumab 10 mg/kg i.v. / 150 mg s.c.","type":"EXPERIMENTAL"},{"label":"Placebo","type":"PLACEBO_COMPARATOR"}],"summary":"This study will assess the efficacy and safety of secukinumab in patients with active ankylosing spondylitis who are intolerant to or have had an inadequate response to NSAIDs, DMARDs and / or TNFα inhibitor therapy.","primaryOutcome":{"measure":"Assessment of Responders for the SpondyloArthritis International Society / ASAS 20 Response","timeFrame":"16 weeks","effectByArm":[{"arm":"Secukinumab 10 mg/kg i.v. / 75 mg s.c.","deltaMin":59.7,"sd":null},{"arm":"Secukinumab 10 mg/kg i.v. / 150 mg s.c.","deltaMin":60.8,"sd":null},{"arm":"Placebo","deltaMin":28.7,"sd":null}],"pValues":[{"comp":"OG000 vs OG002","p":"<0.0001"},{"comp":"OG001 vs OG002","p":"<0.0001"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":5,"exclusionCount":5},"locations":{"siteCount":67,"countries":["United States","Belgium","Bulgaria","Canada","France","Germany","Italy","Mexico","Netherlands","Peru","Russia","Taiwan","Turkey (Türkiye)","United Kingdom"]},"refs":{"pmids":["40489668","34903218","34618347","33722947","33351179","33252266","33227175","32352653","31203228","30564451","28544533","27965257","27390130","26699169"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":16,"n":124},"commonTop":["Nasopharyngitis","Diarrhoea","Headache","Upper respiratory tract infection","Dyslipidaemia"]}}